ATE474935T1 - Verfahren und zusammensetzungen zur bestimmung von mutationen in nukleinsäure und deren verwendung in diagnose von genetischen krankheiten und krebs - Google Patents

Verfahren und zusammensetzungen zur bestimmung von mutationen in nukleinsäure und deren verwendung in diagnose von genetischen krankheiten und krebs

Info

Publication number
ATE474935T1
ATE474935T1 AT04806369T AT04806369T ATE474935T1 AT E474935 T1 ATE474935 T1 AT E474935T1 AT 04806369 T AT04806369 T AT 04806369T AT 04806369 T AT04806369 T AT 04806369T AT E474935 T1 ATE474935 T1 AT E474935T1
Authority
AT
Austria
Prior art keywords
nucleic acid
compositions
cancer
genetic diseases
methods
Prior art date
Application number
AT04806369T
Other languages
English (en)
Inventor
Jean-Louis Viovy
Original Assignee
Inst Curie
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Curie, Centre Nat Rech Scient filed Critical Inst Curie
Application granted granted Critical
Publication of ATE474935T1 publication Critical patent/ATE474935T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04806369T 2003-12-16 2004-12-16 Verfahren und zusammensetzungen zur bestimmung von mutationen in nukleinsäure und deren verwendung in diagnose von genetischen krankheiten und krebs ATE474935T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2003/006016 WO2005061728A1 (en) 2003-12-16 2003-12-16 Methods and compositions for assaying mutations in nucleic acids
PCT/IB2004/004171 WO2005059175A1 (en) 2003-12-16 2004-12-16 Methods and compositions for assaying mutations in nucleic acids and their uses in diagnosis of genetic diseases and cancers

Publications (1)

Publication Number Publication Date
ATE474935T1 true ATE474935T1 (de) 2010-08-15

Family

ID=34685563

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806369T ATE474935T1 (de) 2003-12-16 2004-12-16 Verfahren und zusammensetzungen zur bestimmung von mutationen in nukleinsäure und deren verwendung in diagnose von genetischen krankheiten und krebs

Country Status (10)

Country Link
US (1) US20070281297A1 (de)
EP (1) EP1694862B1 (de)
JP (1) JP2007513637A (de)
CN (1) CN1950517A (de)
AT (1) ATE474935T1 (de)
AU (1) AU2003301503A1 (de)
CA (1) CA2549945A1 (de)
DE (1) DE602004028282D1 (de)
ES (1) ES2348724T3 (de)
WO (2) WO2005061728A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180121599A1 (en) * 2009-09-05 2018-05-03 Vito Nv (Vlaamse Instelling Voor Technologisch Onderzoek) Methods and systems for detecting a nucleic acid in a sample by analyzing hybridization
CN104894255B (zh) * 2015-05-29 2019-09-06 石河子大学 一种基于聚丙烯酰胺凝胶电泳检测低效率基因组编辑的方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US334612A (en) * 1886-01-19 Ofeeating mechanism foe eailwat switches
GB1602745A (en) * 1977-10-13 1981-11-18 Squibb & Sons Inc Inhibiting growth of mycoplasmas
US4794075A (en) * 1985-08-29 1988-12-27 Lifecodes Corporation Method for locating and purifying DNA containing single base mismatches
US5639611A (en) * 1988-12-12 1997-06-17 City Of Hope Allele specific polymerase chain reaction
US5459039A (en) * 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
CA2188660C (en) * 1994-04-25 2005-01-18 Richard G. H. Cotton Detection of mutation by resolvase cleavage
EP0843736B1 (de) * 1995-05-11 1999-12-22 Ulf Landegren Nachweis von fehlpaarungen durch spaltung mit resolvase auf einem festträger
US5654155A (en) * 1996-02-12 1997-08-05 Oncormed, Inc. Consensus sequence of the human BRCA1 gene
WO1999010369A1 (en) * 1997-08-28 1999-03-04 Thomas Jefferson University Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins
US6183958B1 (en) * 1998-05-06 2001-02-06 Variagenics, Inc. Probes for variance detection
CA2387962A1 (en) * 1999-10-22 2001-04-26 Oy Juvantia Pharma Ltd. A dna molecule encoding a variant .alpha.2b-adrenoceptor protein, and uses thereof
US8975328B2 (en) * 2000-06-30 2015-03-10 Institute Curie Non-thermosensitive medium for analyzing species in a channel and for minimizing adsorption and/or electroosomosic phenomena
FR2811083B1 (fr) * 2000-06-30 2002-11-22 Inst Curie Milieu liquide non-thermosensible pour l'analyse d'especes au sein d'un canal
US6632610B2 (en) * 2000-10-12 2003-10-14 Gensat S.A. Methods of identification and isolation of polynucleotides containing nucleic acid differences
EP1349962A4 (de) * 2000-12-08 2007-08-08 California Inst Of Techn Verfahren und zusammensetzungen zum nachweis von schäden an polynukleotidduplexen
EP1798291B1 (de) * 2005-12-13 2011-05-18 Institut Curie Verfahren für die Detektion von Mutationen in Nukleinsaüren, und die Anwendung in der Diagnose von genetischen Krankheiten und Krebs

Also Published As

Publication number Publication date
US20070281297A1 (en) 2007-12-06
DE602004028282D1 (de) 2010-09-02
WO2005059175A1 (en) 2005-06-30
CA2549945A1 (en) 2005-06-30
WO2005061728A1 (en) 2005-07-07
AU2003301503A1 (en) 2005-07-14
CN1950517A (zh) 2007-04-18
JP2007513637A (ja) 2007-05-31
EP1694862A1 (de) 2006-08-30
EP1694862B1 (de) 2010-07-21
ES2348724T3 (es) 2010-12-13

Similar Documents

Publication Publication Date Title
KR102941150B1 (ko) 범-암 백금 반응 예측기
JP7702360B2 (ja) 腫瘍分率を評価するためのシステムおよび方法
Kelloff et al. Cancer biomarkers: selecting the right drug for the right patient
JP6590790B2 (ja) 生体サンプルにおける定量的細胞組成を特定する方法
Guey et al. Genetic susceptibility to distinct bladder cancer subphenotypes
KR20210111254A (ko) 차세대 분자 프로파일링
KR20230044429A (ko) 폐암의 검출을 위한 조성물 및 방법
EP2298936A1 (de) Genomischer fingerabdruck von brustkrebs
DE602005011008D1 (de) Verwendung der Gene Kir2.3 und DRD2 als molekulare Marker zur Diagnose von Schizophrenie
CN107034295A (zh) 用于癌症早期诊断和危险度评价的dna甲基化指标及其应用
KR20190099928A (ko) 위식도경계부선암의 진단 및 표적 치료를 위한 마커
Roth et al. A modified Lynch syndrome screening algorithm in colon cancer: BRAF immunohistochemistry is efficacious and cost beneficial
EP3190191A1 (de) Verfahren und kit zur diagnose von lungenkrebs
Sun et al. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC
KR20210016362A (ko) 결장암 예측 바이오마커로서의 l1td1
KR102139315B1 (ko) Tnfrsf19 유전자의 dna 메틸레이션 변화를 이용한 알츠하이머병 치매 조기진단 마커
KR102313459B1 (ko) 알츠하이머병 치매 특이적 dna 메틸레이션 마커 검출용 조성물 및 검출방법
WO2018186687A1 (ko) 생물학적 시료의 핵산 품질을 결정하는 방법
KR20230028619A (ko) 아토피성 피부염 진단용 바이오마커 및 이의 용도
DE602004028282D1 (de) Verfahren und zusammensetzungen zur bestimmung von mutationen in nukleinsäure und deren verwendung in diagnose von genetischen krankheiten und krebs
Piskareva et al. The human L1 element: a potential biomarker in cancer prognosis, current status and future directions
Kristensen et al. Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer
KR102735655B1 (ko) Atp2c1 유전자의 dna 메틸화 변화를 이용한 알츠하이머병 치매진단 마커
KR20220007132A (ko) 전립선암 및 림프종의 염색체 형태 마커
CN121335988A (zh) 非侵入性体外诊断方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties